See a former colleague of mine Scott Gottlieb getting slimed by the Seattle Times for -- gasp -- knowing something about financial markets. Scott used to write the Gilder Biotech Report and the Forbes Medical Technology Report, and he recently went back to the FDA as one of three deputy commissioners. The reporter seems to think that only people who don't like the pharmaceutical/medical technology industry should work at the FDA. Most people in government have little experience with business and financial markets, and so a Scott Gottlieb here or there is not only not going to hurt anyone but in fact provides a much needed new perspective in an institution that has trailed its foreign counterparts in approving new lifesaving medicines and procedures. We need more people from business and finance to do stints in government, not fewer. America will be healthier with Gottlieb at FDA.
-Bret Swanson
